SEC Form 4 · accession 0000911916-17-000044
ZIMMER BIOMET HOLDINGS, INC. · ZBH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chad F Phipps
Officer — Sr. VP/Gen Counsel/Secretary
Period of report
Feb 2, 2017
Accepted (ET)
Feb 6, 2017 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 2, 2017 | M | 10,500 | $83.68 | A | 44,262 | D | |
| Common StockF1,F3 | Feb 2, 2017 | S | 10,500 | $117.6172 | D | 33,762 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $83.68 | Feb 2, 2017 | M | 10,500 | D | — | Feb 5, 2017 | Common Stock | 10,500 | 0 | D |
Explanation of responses
- F1Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Phipps on August 16, 2016.
- F2Includes 169 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between May 2, 2016 and January 30, 2017 and 249 shares purchased between April 29, 2016 and January 27, 2017 under the dividend reinvestment plan for the Company's common stock.
- F3Represents the sale of 10,500 shares in multiple transactions, ranging in price from $117.32 to $117.90 per share, resulting in a weighted average sale price of $117.6172. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- F4Vested annually over four years in increments of 25% each year, commencing on February 6, 2008.